Racial disparities in non-recommendation of adjuvant chemotherapy in stage II-III ovarian cancer.
Gynecol Oncol
; 164(1): 27-33, 2022 01.
Article
in En
| MEDLINE
| ID: mdl-34785030
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Outcome Assessment, Health Care
/
Chemotherapy, Adjuvant
/
Healthcare Disparities
/
Antineoplastic Agents
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Aspects:
Determinantes_sociais_saude
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Country/Region as subject:
America do norte
Language:
En
Journal:
Gynecol Oncol
Year:
2022
Document type:
Article
Affiliation country:
United States
Country of publication:
United States